"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D001803:Blood Transfusion; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy* / Q000628:therapy; D013156:Splenectomy
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D006854:Hydrocortisone